GlassScriptPhysician profile
Amir Shokrae
NPI 1306934112
$35,302.74
in general payments reported to CMS, 2019-2025
74 companies · $6,555 in 2025
The $6,555 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,455 · 2020: $3,132 · 2021: $3,693 · 2022: $5,011 · 2023: $5,498 · 2024: $6,959 · 2025: $6,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Education: $27.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,983.87 |
| Education | $27.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,121.37 | 2020-2025 | Botox, Ubrelvy, Qulipta |
| Biogen, INC. | $2,700.45 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Ucb, INC. | $2,608.42 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $2,107.11 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $1,881.18 | 2019-2025 | Ultomiris, Soliris |
| Sk Life Science, INC. | $1,564.88 | 2020-2025 | Xcopri |
| Lundbeck LLC | $1,464.24 | 2019-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $1,240.88 | 2019-2025 | Mavenclad |
| Eisai INC. | $1,133.56 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $1,063.26 | 2020-2025 | Ingrezza |
| Amgen INC. | $894.38 | 2019-2025 | Uplizna, Aimovig |
| Amneal Pharmaceuticals LLC | $870.74 | 2019-2025 | Rytary, Crexont, Unithroid |
| Lilly USA, LLC | $834.26 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Argenx US, INC. | $763.97 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $709.62 | 2019-2025 |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $660.57 | 2020-2025 | Austedo, Austedo Xr, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $644.89 | 2019-2022 | |
| Celgene Corporation | $630.69 | 2021-2025 | Zeposia |
| Csl Behring | $607.86 | 2021-2025 | Hizentra |
| Tg Therapeutics, INC. | $607.03 | 2023-2025 | |
| Genzyme Corporation | $568.62 | 2019-2025 | |
| Genentech USA, INC. | $517.77 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Harmony Biosciences LLC | $454.99 | 2021-2025 | Wakix |
| Grifols USA, LLC | $439.98 | 2019-2025 | Gamunex-C |
| Jazz Pharmaceuticals INC. | $399.05 | 2019-2024 | |
| Allergan, INC. | $371.45 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $370.22 | 2021-2025 | Inbrija, Xeomin |
| Ipsen Biopharmaceuticals, INC | $367.80 | 2019-2025 | Dysport |
| Takeda Pharmaceuticals U.S.A., INC. | $347.73 | 2022-2025 | Hyqvia, Gammagard |
| Mdd US Operations, LLC | $335.78 | 2019-2025 | Gocovri, Apokyn |
| Banner Life Sciences, LLC | $324.19 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $316.56 | 2019-2024 | Nuplazid, Daybue |
| Vanda Pharmaceuticals INC. | $309.20 | 2024-2025 | Ponvory |
| Adamas Pharmaceuticals, INC. | $302.89 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $249.34 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $245.79 | 2022 | |
| Janssen Pharmaceuticals, INC | $236.82 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $230.19 | 2020-2021 | |
| Kyowa Kirin, INC. | $199.43 | 2020-2025 | Nourianz |
| Greenwich Biosciences, INC. | $192.84 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $190.98 | 2020-2025 | Fycompa, Firdapse |
| Livanova USA, INC. | $177.33 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Octapharma USA, INC. | $175.77 | 2024-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Neurelis, INC. | $173.34 | 2020-2025 | Valtoco |
| Otsuka America Pharmaceutical, INC. | $162.38 | 2023-2024 | Rexulti, Nuedexta |
| Ge Healthcare | $151.23 | 2020-2023 | |
| Acorda Therapeutics, INC | $130.62 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $124.01 | 2020-2022 | |
| Tanabe Pharma America, INC. | $113.84 | 2019-2025 | Radicava |
| Abbott Laboratories | $110.81 | 2023-2024 | Infinity |
| Astrazeneca Pharmaceuticals LP | $109.56 | 2021-2025 | Wainua |
| Merck Sharp & Dohme LLC | $96.11 | 2020-2023 | Belsomra |
| Scilex Pharmaceuticals INC. | $77.81 | 2023-2024 | Ztlido |
| Vertical Pharmaceuticals, LLC | $76.38 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $59.16 | 2020 | |
| Medtronic, INC. | $55.11 | 2022 | |
| Mallinckrodt Hospital Products INC. | $51.04 | 2020 | |
| Akcea Therapeutics, INC. | $43.75 | 2019-2020 | |
| Cycle Pharmaceuticals INC | $40.59 | 2025 | Tascenso Odt, Bafiertam |
| Neuropace, INC. | $37.95 | 2024 | |
| Amylyx Pharmaceuticals, INC. | $32.48 | 2023 | Relyvrio |
| Horizon Therapeutics Plc | $21.66 | 2021 | |
| Corium, LLC | $21.40 | 2022 | |
| Novo Nordisk INC | $19.35 | 2020 | |
| Azurity Pharmaceuticals, INC. | $19.21 | 2025 | |
| Bausch Health US, LLC | $19.04 | 2022 | |
| Aquestive Therapeutics, INC. | $18.77 | 2021 | |
| Assertio Therapeutics, INC. | $18.46 | 2019 | |
| Merz North America, INC. | $17.16 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $16.12 | 2025 | Lumryz |
| Alfasigma USA, INC. | $15.22 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.83 | 2022 | |
| Almatica Pharma LLC | $11.43 | 2021 | |
| Forte Bio-Pharma LLC | $9.84 | 2019 |
Drugs and devices associated with these payments
Vumerity $1,150Kesimpta $954Qulipta $909Tysabri $897Rystiggo $889Vyepti $845Botox $826Ultomiris $803Ingrezza $793Leqembi $776Ubrelvy $713Briumvi $607Vyvgart Hytrulo $539Briviact $474Zeposia $472Nurtec Odt $462Hizentra $391Wakix $374Rytary $320Zavzpret $319Gamunex-C $313Ponvory $309Panzyga $273Emgality $268Crexont $248Vraylar $222Inbrija $218Hyqvia $203Paxlovid $177Nayzilam $169Amyvid $164Dysport $161Mavenclad $161Bafiertam $159Nourianz $156Rexulti $154Uplizna $149Kisunla $143Vns Therapy Sentiva Model 1000 Generator $142Xeomin $141Comirnaty $141Valtoco $122Gocovri $120Austedo $118Duopa $112Infinity $111Nuplazid $109Zilbrysq $108Avonex $97.83Austedo Xr $91.05Vyalev $90.52Radicava $86.62Octagam Immune Globulin (Human) $84.98Apokyn $80.22Firdapse $79.65Ztlido $77.81Fycompa $72.83Radicava Ors $64.56Ocrevus $61.90Gammagard $57.01Soliris $51.28Enspryng $47.87Plegridy $45.27Xcopri $45.15Nuedexta $40.82Tascenso Odt $40.59Reyvow $39.60Rns Neurostimulator Kit $37.95Agamree $36.06Wainua $34.69Relyvrio $32.48Belsomra $28.32Xywav $28.15Daybue $24.48Vns Therapy $21.77Unithroid $20.49Spinraza $19.30Ocrevus Zunovo $18.34Lumryz $16.12Vyvgart $15.85Aimovig $14.68Mayzent $13.98
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Shokrae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.